Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J-J Grob

Showing results (171-180 of 214) with videos related to

Pageof 22
Sort By:
La Revue De Medecine Interne|February 14, 2024
[High anti-topoisomerase-1 autoantibodies levels are associated with the extension of skin fibrosis and vascular progression in patients with systemic sclerosis]C Dol, B Granel, N Resseguier, et al.
The British Journal of Dermatology|September 30, 2009
Comparators, study duration, outcome measures and sponsorship in therapeutic trials of psoriasis: update of the EDEN Psoriasis Survey 2001-2006L Naldi, A Svensson, D Zenoni, et al.
Dermatology (Basel, Switzerland)|June 17, 2006
Update on the activities of the European Dermato-Epidemiology Network (EDEN)S M Langan, J N Bouwes Bavinck, P J Coenraads, et al.
Archives of Dermatology|February 1, 1990
Spontaneous adult scurvy in a developed country: new insight in an ancient diseaseJ J Grob, A M Collet-Villette, M F Aillaud, et al.
European Journal of Cancer (Oxford, England : 1990)|August 8, 2017
Survival of melanoma patients treated with targeted therapy and immunotherapy after systematic upfront control of brain metastases by radiosurgeryC Gaudy-Marqueste, A S Dussouil, R Carron, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|April 12, 2020
Quality-of-life analysis with intermittent vismodegib regimens in patients with multiple basal cell carcinomas: patient-reported outcomes from the MIKIE studyD Schadendorf, A Hauschild, S Fosko, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|January 29, 2020
Sonidegib and vismodegib in the treatment of patients with locally advanced basal cell carcinoma: a joint expert opinionR Dummer, P A Ascierto, N Basset-Seguin, et al.
The British Journal of Dermatology|April 17, 2021
Not all melanomas are created equal: a review and call for more research into nodular melanomaC Dessinioti, A C Geller, D C Whiteman, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 27, 2017
Incidence, course, and management of toxicities associated with cobimetinib in combination with vemurafenib in the coBRIM studyB Dréno, A Ribas, J Larkin, et al.
Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology|July 4, 2012
Component-resolved diagnosis with commercially available D. pteronyssinus Der p 1, Der p 2 and Der p 10: relevant markers for house dust mite allergyM Bronnert, J Mancini, J Birnbaum, et al.
Pageof 22

Showing results (171-180 of 214) with videos related to

Sort By:
Pageof 22
La Revue De Medecine Interne|February 14, 2024
[High anti-topoisomerase-1 autoantibodies levels are associated with the extension of skin fibrosis and vascular progression in patients with systemic sclerosis]C Dol, B Granel, N Resseguier, et al.
The British Journal of Dermatology|September 30, 2009
Comparators, study duration, outcome measures and sponsorship in therapeutic trials of psoriasis: update of the EDEN Psoriasis Survey 2001-2006L Naldi, A Svensson, D Zenoni, et al.
Dermatology (Basel, Switzerland)|June 17, 2006
Update on the activities of the European Dermato-Epidemiology Network (EDEN)S M Langan, J N Bouwes Bavinck, P J Coenraads, et al.
Archives of Dermatology|February 1, 1990
Spontaneous adult scurvy in a developed country: new insight in an ancient diseaseJ J Grob, A M Collet-Villette, M F Aillaud, et al.
European Journal of Cancer (Oxford, England : 1990)|August 8, 2017
Survival of melanoma patients treated with targeted therapy and immunotherapy after systematic upfront control of brain metastases by radiosurgeryC Gaudy-Marqueste, A S Dussouil, R Carron, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|April 12, 2020
Quality-of-life analysis with intermittent vismodegib regimens in patients with multiple basal cell carcinomas: patient-reported outcomes from the MIKIE studyD Schadendorf, A Hauschild, S Fosko, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|January 29, 2020
Sonidegib and vismodegib in the treatment of patients with locally advanced basal cell carcinoma: a joint expert opinionR Dummer, P A Ascierto, N Basset-Seguin, et al.
The British Journal of Dermatology|April 17, 2021
Not all melanomas are created equal: a review and call for more research into nodular melanomaC Dessinioti, A C Geller, D C Whiteman, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 27, 2017
Incidence, course, and management of toxicities associated with cobimetinib in combination with vemurafenib in the coBRIM studyB Dréno, A Ribas, J Larkin, et al.
Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology|July 4, 2012
Component-resolved diagnosis with commercially available D. pteronyssinus Der p 1, Der p 2 and Der p 10: relevant markers for house dust mite allergyM Bronnert, J Mancini, J Birnbaum, et al.
Pageof 22